(lp0
S'Brokerage Views in Focus For iBio, Inc.  Cancer Genetics, Inc. (NASDAQ ... Rives Journal - 16 hours ago Brokerage firms currently have a positive stance on shares of iBio, Inc. . The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.00.'
p1
aS'iBio, Inc.  Receives Favorable Court Ruling in Fraunhofer USA Litigation StreetInsider.com - Aug 4, 2016 iBio, Inc.  announced that the Delaware Court of Chancery, where litigation brought by iBio against Fraunhofer USA Inc. has been pending, issued a decisive determination on July 29, 2016, in favor of iBio and against Fraunhofer.'
p2
aS'iBio, Inc. , Eastern Capital Enter JV to Develop Plant-Made Pharmaceuticals StreetInsider.com - Jan 14, 2016 iBio, Inc.  announced the formation of a joint venture with affiliates of Eastern Capital Limited  to develop and manufacture plant-made pharmaceuticals.iBio Forms Joint Venture CMO for Large-Scale Pharmaceuticals Manufacturing in ... - CNNMoney'
p3
aS'Trading Sheet: Tracking Technicals for Ibio Inc  Rives Journal - Mar 21, 2017 Ibio Inc  has a 14-day Commodity Channel Index  of -22.67. The CCI was designed to typically remain within the reading of -100 to +100.'
p4
aS'What Happened to Ibio Inc  MicroCap Daily - May 17, 2015 Ibio Inc  continues to make higher highs and higher lows since reversing off $0.50 lows in February. The stock made a spectacular move up in October of last year after IBIO offered to assist the U.S.'
p5
aS'iBio, Inc. Receives FDA Orphan Drug Designation for Fibrosis Product Candidate Yahoo Finance - Jul 5, 2016 NEW YORK, NY-- - iBio, Inc. , a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced that the United States Food and Drug Administration  has&nbsp;...'
p6
aS'iBio, Inc.  Files An 8-K Departure of Directors or Certain ... Market Exclusive - Mar 6, 2017 iBio, Inc.  Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.'
p7
aS'iBio Grants Caliber License for Production of Antibodies Targeting Ebola Marketwired  - Nov 10, 2014 NEWARK, DE-- - iBio, Inc.  and Caliber Biotherapeutics LLC executed an agreement, effective today, for an emergency use license to the iBioLaunch platform for production by Caliber of antibodies that ...'
p8
aS'iBio, Inc.  Files An 8-K Entry into a Material Definitive Agreement Market Exclusive - Feb 24, 2017 iBio, Inc. is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators.'
p9
aS"Market Mover of Last Trading Session: iBio, Inc.  Is stories - Feb 24, 2017 iBio, Inc.'s  witnessed a loss of -1.99% in recent trading period with closing price of $ 0.38. The company's last traded volume of 0.15 million shares as compared to it's an average volume of 0.1 million shares."
p10
a.